ChemBK
  • Home
  • Product Category


Prinaberel

ERB 041

CAS: 524684-52-4

Molecular Formula: C15H10FNO3

  1. Home
  2. Product Category
  3. Biochemical reagent
  4. Prinaberel

Prinaberel - Names and Identifiers

Name ERB 041
Synonyms ERB 041
PRINABEREL
WAY-202041
Prinaberel
Prinaberel (ERB 041)
2-(3-Fluoro-4-hydroxyphenyl)- 7-vinylbenzoxazol-5-ol
7-Ethenyl-2-(3-fluoro-4-hydroxyphenyl)-5-benzoxazolol
5-Benzoxazolol, 7-ethenyl-2-(3-fluoro-4-hydroxyphenyl)-
2-(3-Fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
CAS 524684-52-4
InChIKey MQIMZDXIAHJKQP-UHFFFAOYSA-N

Prinaberel - Physico-chemical Properties

Molecular FormulaC15H10FNO3
Molar Mass271.24
Density1.413
Melting Point250-252 ºC
Boling Point451.6±45.0 °C(Predicted)
Solubility DMSO: ≥25mg/mL
Appearancepowder
Colorwhite to tan
pKa7.50±0.20(Predicted)
Storage Conditionroom temp
In vitro study Prinaberel (ERB-041) (0-60 µM; 24 hours) treatment of human SCC cells induces cell differentiation, cell cycle arrest and reduces colony formation. Prinaberel shows a marked reduction in the expression of inflammation regulatory proteins such as p-NFκBp65, iNOS and COX-2 in A431 cells. Prinaberel diminishes phosphorylated-PI3K and -AKT, which is associated with the enhancement in E-cadherin expression and reduction in migration of A431 cells. Prinaberel (0.01-10 µM) inhibits cell proliferation in a dose- and time-dependent manner. Prinaberel (10 µM; 48 hours) promotes ovarian cancer (SKOV-3 cells) apoptosis. Western Blot Analysis Cell Line: A431 cells Concentration: 0, 20, 40 and 60 µM Incubation Time: 24 hours Result: Reduction in the expression of G1 cyclins (D1, D2 and D3) and CDK4. Cell Proliferation Assay Cell Line: SKOV-3, A2780CP or OVCAR-3 cells Concentration: 0.01, 0.1 and 10 µM Incubation Time: 24-48 hours Result: Showed significantly inhibitory effect on cell proliferation.
In vivo study Prinaberel (2mg/mouse; topically; 30 min prior to UVB irradiation for 30 weeks) suppresses development of squamous cell carcinoma in SKH-1 hairless mice. Prinaberel reduces proliferation and angiogenesis and induces apoptosis in UVB-induced skin tumors. Prinaberel suppresses pro-inflammatory signaling pathway in UVB-induced skin tumors. Prinaberel diminished tumor invasiveness via PI3K-AKT pathway and WNT signaling. Animal Model: Six- to eight-weeks-old SKH-1 hairless female mice Dosage: 2 mg/mouse in 200µl ethanol Administration: Topically; 30 min prior to UVB (180mJ/cm2) irradiation for 30 weeks Result: Diminished UVB-induced skin tumor development in SKH-1 hairless mice.

Prinaberel - Risk and Safety

Hazard SymbolsXn - Harmful
Harmful
Risk CodesR22 - Harmful if swallowed
R36 - Irritating to the eyes
Safety Description26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
WGK Germany3

Prinaberel - Preparation solution concentration reference

 1mg5mg10mg
1 mM3.687 ml18.434 ml36.868 ml
5 mM0.737 ml3.687 ml7.374 ml
10 mM0.369 ml1.843 ml3.687 ml
5 mM0.074 ml0.369 ml0.737 ml
Last Update:2024-01-02 23:10:35

Prinaberel - Reference Information

biological activity Prinaberel (ERB-041) is an effective selective estrogen receptor β (ERβ) agonist, the IC50 of human, rat and mouse ERβ is 5.4, 3.1 and 3.7 nM respectively. The selectivity of Prinaberel to ERβ is more than 200 times that of ERα. Prinaberel is an effective chemopreventive agent for skin cancer and can play a role by inhibiting WNT/β-catenin signaling pathway. Prinaberel induces apoptosis in ovarian cancer cells (apoptosis).
target hERβ 5.4 nM (IC 50 ) rat ERβ 3.1 nM (IC 50 ) mouse ERβ 3.7 nM (IC 50 ) hERα 1200 nM (IC 50 ) mouse ERα 750 nM (IC 50 ) rat ERα 620 nM (IC 50 )
in vitro study Prinaberel (ERB-041) (0-60µM; 24 hours) treatment of human SCC cells induces cell differentiation, cell cycle arrest and reduces colony formation. Prinaberel shows a marked reduction in the expression of inflammation regulatory proteins such as p-NFκBp65, iNOS and -2 in A431 cells. Prinaberel diminishes phosphorylated-PI3K and -AKT, which is associated with the enhancement in E-cadherin expression and reduction in migration of A431 cells. Prinaberel (0.01-10 m) inhibits cell proliferation in a dose- and time-dependent manner. Prinaberel (10 m; 48 hours) promotes ovarian cancer (SKOV-3 cells) apoptosis. Western Blot Analysis Cell Line: A431 cells Concentration: 0,20, 40 and 60 m Incubation Time: 24 hours Result: reduction in the expression of G1 cyclins (D1, D2 and D3) and CDK4. Cell Proliferation Assay Cell Line: SKOV-3, A2780CP or OVCAR-3 cells Concentration: 0.01, 0.1 and 10 µM Incubation Time: 24-48 hours result: Showed significantly inhibitory effect on cell proliferation.
Cell Line: A431 cells
SKOV-3, A2780CP or OVCAR-3 cells
Concentration: 0, 20, 40 and 60 µM
0.01, 0.1 and 10 µM
Incubation Time: 24 hours
24-48 hours
Result: Reduction in the expression of G1 cyclins (D1, D2 and D3) and CDK4.
Showed significantly inhibitory effect on cell proliferation.
Diminished UVB-induced skin tumor development in SKH-1 hairless mice.
in vivo study Prinaberel (2 mg/mouse; topically; 30 min prior to UVB irradiation for 30 weeks) suppresses development of squamous cell carcinoma in SKH-1 hairless mice. Prinaberel reduces proliferation and angiogenesis and induces apoptosis in UVB-induced skin tumors. Prinaberel suppresses pro-inflammatory signaling pathway in UVB-induced skin tumors. Prinaberel diminished tumour invasiveness via PI3K-AKT pathway and WNT signaling. Animal Model: six-to eight-weeks-old SKH-1 hairless female mice Dosage: 2 mg/mouse in 200 µl ethanol Administration: Topically; 30 min prior to UVB (180mJ/cm2) irradiation for 30 weeks result: Diminished UVB-induced skin development in SKH-1 hairless mice.
Animal Model: Six- to eight-weeks-old SKH-1 hairless female mice
Dosage: 2 mg/mouse in 200µl ethanol
Administration: Topically; 30 min prior to UVB (180mJ/cm2) irradiation for 30 weeks
Last Update:2024-04-09 20:52:54
Prinaberel
Supplier List
MedChemExpress (MCE)
Spot supply
Product Name: ERB-041 Visit Supplier Webpage Request for quotation
CAS: 524684-52-4
Tel: 609-228-6898
Email: sales@medchemexpress.com
     tech@medchemexpress.com
Mobile: 609-228-6898
SHANGHAI ACMEC BIOCHEMICAL TECHNOLOGY CO., LTD.
Spot supply
Product Name: Prinaberel Visit Supplier Webpage Request for quotation
CAS: 524684-52-4
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922 Click to send a QQ message
Wechat: 18621343501
WhatsApp: +86-18621343501
Shanghai Macklin Biochemical Co., Ltd
Spot supply
Product Name: Prinaberel Visit Supplier Webpage Request for quotation
CAS: 524684-52-4
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328 Click to send a QQ message
WhatsApp: +86-18821248368
Shanghai Yuanye Bio-Technology Co., Ltd.
Product Name: ERB 041 Visit Supplier Webpage Request for quotation
CAS: 524684-52-4
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409 Click to send a QQ message
MedChemExpress (MCE)
Spot supply
Product Name: ERB-041 Visit Supplier Webpage Request for quotation
CAS: 524684-52-4
Tel: 609-228-6898
Email: sales@medchemexpress.com
     tech@medchemexpress.com
Mobile: 609-228-6898
SHANGHAI ACMEC BIOCHEMICAL TECHNOLOGY CO., LTD.
Spot supply
Product Name: Prinaberel Visit Supplier Webpage Request for quotation
CAS: 524684-52-4
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922 Click to send a QQ message
Wechat: 18621343501
WhatsApp: +86-18621343501
Shanghai Macklin Biochemical Co., Ltd
Spot supply
Product Name: Prinaberel Visit Supplier Webpage Request for quotation
CAS: 524684-52-4
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328 Click to send a QQ message
WhatsApp: +86-18821248368
Shanghai Yuanye Bio-Technology Co., Ltd.
Product Name: ERB 041 Visit Supplier Webpage Request for quotation
CAS: 524684-52-4
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409 Click to send a QQ message
View History
Prinaberel
3-(9-咔唑基)苯硼酸频呢醇酯
2-乙基-3-乙酰基苯并呋喃
2-(3,6-二乙酰氧基-2,7-二氯-9H-氧杂蒽-9-基)苯甲酸
  • Home
  • Product Category

© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001